Alloksys Life Sciences BV is a pioneering company in the field of alkaline phosphatase-based medical interventions for critical care patients. 𝐑𝐄𝐒𝐂𝐀𝐏® (RESCuing Alkaline Phosphatase) is the proprietary name for our medication based on the enzyme alkaline phosphatase (AP). AP is naturally present in the body and is part of the innate immune system (‘first line of defence’). In the rapidly growing critical care market, there is a high demand for solutions that enhance patient recovery, stability, and reduce complications. Alloksys is determined to make 𝐑𝐄𝐒𝐂𝐀𝐏® available to those who can benefit from it and is committed to bringing it to the market.